Neovacs: Investor Presentation (Neovacs) - Jul 3, 2015 - Anticipated expiry of composition of matter patent in US in 2017; Anticipated expiry of composition of matter patent in EU and US in 2020; Anticipated expiry of composition of matter patent in EU, US, Canada, China, South Africa, Australia, Japan, Brazil, India, New Zealand in 2023; Anticipated expiry of composition of matter patent in EU, US, Canada, and Japan in 2024; Anticipated expiry of method of use patent in EU, US, Canada, China, Australia, Japan, Brazil, Israel, Mexico, India, Korea, Russia in 2032
Anticipated patent expiry • Immunology • Lupus
|